Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IV Study Safety & Feasibility of Sodium Oxybate in Mild Alzheimer's Disease Patients.

NCT00706186 is registered in ClinicalTrials.gov with Clayton Sleep Insititute as lead sponsor.

NCT NCT00706186
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00706186 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IV Study Safety & Feasibility of Sodium Oxybate in Mild Alzheimer's Disease Patients.
Lead sponsor
Clayton Sleep Insititute
Phase
Phase 4
Overall status
Terminated
Start date
Not reported
Completion date
Not reported
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mild alzheimer's disease